At Gencell Pharma, I analyzed NGS data for molecular diagnostics, using genomic databases to support diagnostic medical decisions. I interpreted sequencing results and classified genetic variants according to ACMG standards.
I also reviewed data integrity and clinical validation processes to help ensure patient reports were accurate and reliable. I collaborated with multidisciplinary medical teams to validate and communicate molecular diagnostic results.
At Corpogen, I analyzed metagenomic data from Illumina and NanoPore sequencing, processed genomic files, and assessed sequencing quality metrics. I also contributed to identifying and characterizing biosynthetic gene clusters and designed primers for genomic regions of interest.
